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Early Primary Open-Angle Glaucoma
Introduction
Glaucoma is the leading cause of irreversible blindness worldwide and 
is projected to affect more than 79.6 million people by 2020, over 10% of 
whom will be bilaterally blind.1 
This multifactorial progressive optic neuropathy causes characteristic reti-
nal nerve fiber layer damage that will eventually lead to associated glauco-
matous visual field defects if left untreated. Unfortunately, these visual field 
defects are difficult for the patient to detect until more advanced stages 
and, as a result, early glaucoma is usually asymptomatic.2 
This paper presents a case that is consistent with population studies that 
suggest that as many as half of people with glaucoma are unaware that they 
have the disease.3
CASE REVIEW
A healthy 71-year-old Caucasian male reported to our office as a new patient 
with complaints of mild blurry vision, OD=OS, at both distance and near.
The patient reported that he had had an eye exam “6-7 years” prior to our 
exam and was told that he had “symptoms of glaucoma”; however, he was 
not diagnosed with glaucoma and did not receive additional treatment. He 
denied any family history of glaucoma, was in good general health, and re-
ported no other difficulties involving either eye.   
The patient was self-medicating with 81mg aspirin, multi-vitamins, fish oil 
capsules, vitamin B complex, and red yeast rice capsules, all taken once daily.
His most recent blood pressure was 150/67 at 14:05 in the seated position, 
while his A1C was 5.8% and his blood glucose level was 116 mg/dL at 14:37. 
His body mass index was 28. No allergies to any medications were reported.
The patient’s unaided entering distance visual acuities and pinhole acu-
ities (PH) were:
OD: 20/60-1 PH: 20/25
OS: 20/40+2 PH: 20/25+2
Subjective refraction and best-corrected visual acuities were:
OD: -0.75 -1.50 x070 20/20
OS: -0.25 -1.50 x062 20/25+1
Preliminary testing showed that the pupils were equally round and reac-
tive to light with no relative afferent pupillary defect. Confrontation visual 
fields were full to finger count OD, OS. Motility testing was full without 
restriction or pain OD, OS.
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Slit lamp examination showed mild bilateral blepharitis, clear conjunctiva, and clear cornea without endothelial 
pigment or keratic precipitates. The anterior chamber was deep and quiet by Van Herick angle estimation and the 
iris was normal without signs of atrophy, obvious posterior synechiae, or trans-illumination defects. Intraocular 
pressures (IOP) were 17 OD, 15 OS at 08:01 by Goldmann applanation tonometry.
Dilated examination showed trace nuclear sclerosis and cortical opacities without evidence of pseudoexfoliation or 
pigment. The macula, vessels, and periphery were all normal OD, OS. There was a posterior vitreous detachment 
OD, OS with no evidence of peripheral retinal abnormality.
The optic nerve head was average to large size OD>OS based on the vertical disc height using the adjusted slit 
lamp graticule and a Volk 78 D lens with a correction factor of 1.2x. The optic cup was of moderate depth, with 
early visible laminar dots OU. There was mild alpha zone parapapillary atrophy, but no signs of pallor or disc 
hemorrhages OU. There was a subtle inferior retinal nerve fiber layer wedge defect with associated inferior 
rim thinning, inferior vessel baring, and inferior arteriole narrowing OU. Additionally, the superior rim was 
suspicious for glaucomatous optic neuropathy OU with evidence of early vessel baring OD>OS and relative 
thinning compared to other optic nerve sectors. Cup-to-disc ratios were estimated to be 0.7 v/0.7 h OD and 
0.75 v/0.7 h OS. 
Baseline photos and optical coherence tomography (OCT) Optic Nerve Head (ONH) and Retinal Nerve Fiber Layer 
(RNFL) Analysis were acquired. Both subjective and objective imaging confirmed the findings in the clinical exam, 
as shown in Figures 1 and 2.
Figure 1: Retinal images showing inferior-temporal localized retinal nerve fiber layer defects with associated inferior-tempo-
ral neuroretinal rim thinning. Note the early relative superior neuroretinal rim thinning OU.
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Figure 1: Retinal images showing inferior-temporal localized retinal nerve fiber 
layer defects with associated inferior-temporal neuroretinal rim thinning. Note 
the early relative superior neuroretinal rim thinning OU. 
The patient was given a provisional diagnosis of early glaucoma, OS>OD, and asked to return within 1 month for 
repeat IOP measurements with baseline gonioscopy, pachymetry, and threshold visual field testing.
At the one-month follow-up appointment, the patient was found to have stable acuities without any additional 
ocular complaints. His intraocular pressures were slightly higher than baseline, at 21 OD, 19 OS at 10:42 am by 
Goldmann applanation tonometry. Pachymetry yielded central corneal thickness measurements that were slightly 
thinner than average, at 524u OD, 525u OS. Gonioscopy showed that the ciliary body was visible in all four quadrants 
with flat iris insertion, light trabecular meshwork pigmentation, and no evidence of peripheral anterior synechiae 
or angle recession OD, OS. 
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Figure 2: Optical coherence tomography (OCT) Optic Nerve Head (ONH) and Retinal Nerve Fiber Layer (RNFL) Analysis 
OU. Note the bilateral nasal posterior vitreous detachments with associated artifacts observed on the RNFL Thickness 
and Deviation Maps. Furthermore, the RNFL thinning is localized and, as such, is only noted on the RNFL Clock Hours 
Map while appearing as “normal” on the RNFL Quadrant Map.
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Figure 2: Optical coherence tomography (OCT) Optic Nerve Head (ONH) and 
Retinal Nerve Fiber Layer (RNFL) Analysis OU. Note the bilateral nasal posterior 
vitreous detachments with associated artifacts observed on the RNFL Thickness 
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Baseline threshold visual field testing (Humphrey 24-2 SITA Fast) showed normal-sensitivity OD with good reli-
ability (0/10 fixation losses, 5% false positives, and 0% false negatives) and several focally depressed superior nasal 
defects OS with lower reliability (5/11 fixation losses, 3% false positives, and 8% false negatives). 
Figure 3: Baseline Humphrey 24-2 SITA Fast visual field plots show focally depressed defects OS only.
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Due to the normal gonioscopic appearance of the angle, the patient was given a more specific diagnosis of early 
primary open angle glaucoma OS>OD with questionable early perimetric defects OS based on the SITA Fast testing 
algorithm. Bengtsson and Heijl4 found that SITA Fast test times (avg 5.0 min) were significantly shorter than Full 
Threshold (avg 14.6 min) and Fastpac (avg 9.4 min) test times, but were essentially equal in terms of reproducibility. 
However, as expected, the sensitivity for detecting shallow (subtle) defects was greater with Full Threshold test-
ing. In other words, shallow defects noted in Full Threshold testing were progressively less visible (perhaps even 
absent) with Fastpac and SITA Fast, while the detection of deeper focal defects was essentially identical with all 
three strategies. 
Through collaboration with the patient, we decided to monitor the condition closely at that time without treatment 
until repeat structural and functional testing confirmed the suspected defects (and/or suggested progression) and 
to further establish baseline intraocular pressures at various diurnal time points. However, based on the case find-
ings thus far, and based on the Early Manifest Glaucoma Trial (EMGT) and the Collaborative Normal Tension Glau-
coma Study (CNTGS), treatment will likely be initiated to help reduce the risk of disease progression. Furthermore, 
and perhaps more specific to our patient, Kim et al. found that sufficient IOP reduction slowed disease progression 
even in patients with suspected preperimetric glaucoma.5 
The patient was asked to return to our office in 3-4 months for repeat tonometry, pachymetry, and 24-2 thresh-
old visual field testing, as well as baseline optical coherence tomography Ganglion Cell Analysis and 10-2 visual 
field testing. As a brief review, the importance (and benefits) of central 10-degree visual field analysis cannot 
be overstated: approximately 50% of eyes with mild-moderate glaucoma were found to have defects within the 
central 3 degrees,6 11 eyes with normal 24-2 visual fields outside the central 10 degrees showed arcuate defects 
within the central 10 degrees with 10-2 testing,7 nine percent of normal 30-2 threshold visual fields in glaucoma 
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suspect or early glaucoma patients were actually classified as abnormal with 10-2 testing8 and approximately 
50% of eyes will show macular glaucomatous damage on 10-2 testing while being classified as normal with just 
24-2 testing.9
DISCUSSION
Weinreb et al. proposed a glaucoma continuum - a spectrum of structural and functional stages in glaucoma in 
which the patient generally progresses from “normal” and asymptomatic disease to functional blindness – with 
structural glaucomatous changes usually preceding functional symptoms.10 The World Glaucoma Association 
also described this temporal relationship between structural and functional changes throughout the course of 
the disease11 and both representations suggest that structural changes are usually detected prior to functional 
changes. However, and as an important reminder from Alasil et al.’s retrospective study and their findings of a 
structural and functional “tipping point”, both structural and functional tests are still necessary to assess early 
glaucomatous damage.12
The American Academy of Ophthalmology Preferred Practice Pattern (AAO PPP) for Primary Open-Angle Glau-
coma states that mild (early) glaucoma is characterized by “optic nerve abnormalities consistent with glaucoma 
[such as] … diffuse thinning, focal narrowing, or notching of the optic disc rim, especially at the inferior or supe-
rior poles; progressive narrowing of the neuroretinal rim with an associated increase in cupping of the optic disc; 
diffuse or localized abnormalities of the parapapillary RNFL [retinal nerve fiber layer], especially at the inferior 
or superior poles; disc rim, parapapillary RNFL, or lamina cribrosa hemorrhages; [and/or] optic disc neural rim 
asymmetry of the two eyes consistent with loss of neural tissue” in the presence of “a normal visual field as tested 
with standard automated perimetry.”13
In the American Optometric Association Optometric Clinical Practice Guidelines (AOA CPG), mild glaucoma is 
defined as an optic nerve with “mild concentric narrowing or partial localized narrowing of the neuroretinal rim; 
disc hemorrhage; [and/or] cup/disc asymmetry”. Furthermore, the nerve fiber layer shows a “less bright reflex; 
fine striations to texture; [and/or] large retinal blood vessels [that appear relatively] clear [whereas] medium 
retinal blood vessels [are] less blurred [and] small retinal blood vessels [are] blurred”. However, unlike the AAO 
PPP, the AOA CPG says that early glaucoma may show “isolated paracentral scotomas, partial arcuate or nasal 
step [defects]; [and that the] damage [is] limited to one hemifield with fewer than 25% of points involved, [with a] 
mean deviation (MD) less than -6dB”.14 A more succinct definition that seems to help bridge the two above defi-
nitions is given by Song and Caprioli: “a progressive optic neuropathy that is defined by characteristic structural 
changes of the optic nerve with corresponding functional changes of the visual field.”15
Nonetheless, once functional loss is detectable, the severity of the glaucomatous optic neuropathy increases with 
the severity of the visual field loss, as shown by Ng et al.16
The present patient presented with several risk factors for open-angle glaucoma,17,18 including his slightly elevat-
ed intraocular pressure with mild fluctuation19 (albeit based on only two isolated readings) and his mid-advanced 
age.20,21 However, additional risk factors that were not applicable to this case, but which should also be considered, 
include presence of lenticular exfoliation,22,23 glaucomatous disc hemorrhages,24-28 African-American ancestry,29 a 
first-degree history of glaucoma,30 and a general history of diabetes31 or hypertension.32-34
The primary clinical sign that was most convincing that this patient did indeed have glaucoma was the appear-
ance of the optic nerve and retinal nerve fiber layer. Specifically, the inferior retinal nerve fiber layer defects 
with associated inferior rim thinning, inferior vessel baring, and inferior arteriole narrowing (and potential 
superior rim thinning) are all characteristic of early glaucoma. Because of this preferential pattern of neuro-
retinal rim loss, the ISNT Rule35,36 mnemonic has been proven to be very effective in differentiating normal 
optic nerves from those with early glaucomatous damage. Furthermore, the absence of rim pallor helps rule 
out other optic neuropathies (ischemic, infiltrative, traumatic, toxic, metabolic, and compressive) that could 
also result in retinal nerve fiber layer defects and arteriole narrowing, and which would necessitate a more 
through systemic workup, possibly including blood work and neuroimaging.37-39 Baseline photos were taken 
to assist in monitoring for future structural progression40 that would manifest as widening of the nerve fiber 
layer defects (locations of future progression and correlating visual field defects41), increased rim thinning/
vessel baring/arteriole narrowing, increased parapapillary atrophy, and/or further nasalization of the central 
retinal vessel trunk.
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Subjective evaluation of serial photos and objective imaging (OCT) are complementary structural evaluations used 
in concert with regular functional (visual field) assessment to monitor for progression. All are necessary: the World 
Glaucoma Association notes that “(c)urrently, no specific test can be regarded as the perfect reference standard 
for detection of glaucomatous structural and/or functional progression”.41 Supporting this position, Banegas et al. 
reported that, in their observational study of 246 eyes, glaucomatous progression was detected in 6.9% of eyes 
by stereo photos, 15% of eyes by visual field testing, and 25.6% of eyes by OCT-guided progression analysis (GPA) 
software. Interestingly, of those cases that showed progression, most were only discovered by either stereophotos, 
perimetry, or OCT testing alone, suggesting a lower percentage of positive agreement among evaluation methods, 
and emphasizing the importance of using all three to monitor for change.42,43 In this situation, the clinical appear-
ance of the ONH correlated very well with the baseline RNFL OCT testing, establishing supporting subjective and 
objective structural baselines.
In support of making a diagnosis of glaucoma based solely on the appearance of the optic nerve and not waiting 
for the development of correlating glaucomatous visual field defects, Sommer et al. suggested in 1977 that glauco-
matous nerve fiber layer defects (such as those observed in this patient) may develop several years prior to reliable 
glaucomatous visual field defects.44 Furthermore, and more recently, Kuang et al. found that RNFL defects observed 
on OCT testing were noted up to 8 years prior to associated glaucomatous visual field defects.45 Consistent with 
these findings, histological studies have found that as much as 50% of retinal ganglion cells are lost prior to clinically 
detectable visual field defects46 - resulting in a “broken-stick” correlation model between retinal nerve fiber thick-
ness and glaucomatous visual fields, as described previously by Alasil et al.12
As mentioned previously, despite the clinically correlating information suggesting early open-angle glaucoma, 
collaboration with the patient determined that we did not initiate treatment for the following 3 reasons:
1. To establish a baseline IOP range in light of potential fluctuation in initial IOP measurements,
2. To establish baseline visual field reproducibility and reliability,47
3. To establish rate of progression, in recognition of the fact that not all patients with glaucoma  
will progress to the point of visual symptoms affecting their activities of daily living.48
CONCLUSION
Elevated intraocular pressure is the primary (and currently the only readily modifiable) risk factor for the 
development of glaucoma and glaucoma progression.49-53 Accordingly, if treatment is required in the future, 
we will work with the patient to establish a customized, unique target IOP range – the “upper limit of a range 
of IOP at which it is judged likely to retard further optic nerve damage”54 and to minimize associated visual 
field loss.55 It is very important to balance this dynamic IOP range with quality-of-life factors including the 
estimated lifetime risk of visual disability for the patient, the potential side-effects of treatment options (topi-
cal vs. laser vs. minimally-invasive glaucoma surgery), the financial burden of treatment, and the instillation 
technique/capability.
Primary open angle glaucoma can be missed in its early stages due to its asymptomatic nature, subtle optic nerve 
morphological changes, and often pre-perimetric presentation. For these reasons, vigilance is required, as we have 
the best success of preserving a lifetime of functional vision for the patient if we can diagnose glaucoma earlier and, 
if needed, treat glaucoma sooner. l
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